This review highlights the role of PRKAR1A mutations in Carney complex and primary pigmented nodular adrenocortical disease, suggesting its function as a tumor-suppressor gene.
No takes yet. Share an insight, caveat, or question.
May guide genetic screening in Carney complex; leaves open PRKAR1A as therapeutic target in tumorigenesis.
Bossis et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: